Skip to main content
AIMD
NASDAQ Life Sciences

Insider's Stake in Ainos, Inc. Jumps to 10.98% Following Significant RSU Grant

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.97
Mkt Cap
$14.314M
52W Low
$1.26
52W High
$4.5
52W Position info
56% above low
Off High info
56% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

AIMD sits 56% above its 52-week low of $1.26 on light trading volume (0.2× avg).

Summary

Ting Chuan Lee's beneficial ownership in Ainos, Inc. increased to 10.98% after receiving a grant of 570,000 fully vested RSUs, valued at over $1.1 million.


Key Events · Ownership and Investor Activity · AIMD

  • Significant RSU Grant to Insider

    Ting Chuan Lee received 570,000 fully vested Restricted Stock Units on April 15, 2026, under the Ainos, Inc. 2023 Stock Incentive Plan.

  • Beneficial Ownership Increases to 10.98%

    Following the RSU grant, Ting Chuan Lee's beneficial ownership in Ainos, Inc. now totals 935,707 shares, representing 10.98% of the common stock outstanding.

  • Substantial Equity Value

    The RSU grant is valued at approximately $1.12 million based on the current stock price of $1.97 per share.


Analysis · AIMD · Life Sciences

Ting Chuan Lee, a reporting person, significantly increased his beneficial ownership in Ainos, Inc. to 10.98% of outstanding shares after receiving a grant of 570,000 fully vested Restricted Stock Units. This substantial equity award, valued at over $1.1 million, aligns insider interests with shareholder value, especially as the company faces a "going concern" warning from its recent 10-K filing. The increase in insider ownership could signal confidence in the company's future despite its financial challenges, potentially providing a boost to investor sentiment.

At the time of this filing, AIMD was trading at $1.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14.3M. The 52-week trading range was $1.26 to $4.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AIMD - Latest Insights

AIMD
Jul 24, 2026, 12:16 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.52
Real-time Price: $1.27 info
Change: -$0.2452 (-16%) info
Market Cap: $11.167M info
AIMD
Jul 10, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.89
Real-time Price: $1.27 info
Change: -$0.6202 (-33%) info
Market Cap: $11.167M info
AIMD
May 20, 2026, 8:00 AM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $1.60
Real-time Price: $1.27 info
Change: -$0.3302 (-21%) info
Market Cap: $11.167M info
AIMD
May 13, 2026, 5:15 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.85
Real-time Price: $1.27 info
Change: -$0.5802 (-31%) info
Market Cap: $11.167M info
AIMD
May 13, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.85
Real-time Price: $1.27 info
Change: -$0.5802 (-31%) info
Market Cap: $11.167M info